Search

Search Results

• 

  Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

  Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

  176-183

  06-07-2016

  https://doi.org/10.4081/itjm.2016.715

  1679

  PDF: 1054

  HTML: 354

• Assessment and predictors of inappropriate dose of direct oral anticoagulants

  Mosaad O. Almegren

  09-01-2024

  https://doi.org/10.4081/itjm.2024.1679

  1297

  pdf: 613

  HTML: 170
• 

  Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

  Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

  314-322

  15-12-2015

  https://doi.org/10.4081/itjm.2015.468

  2141

  PDF: 1034

  HTML: 1287

• The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

  Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

  17-02-2025

  https://doi.org/10.4081/itjm.2025.1807

  2380

  PDF: 556

  HTML: 1
• 

  The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

  Luca Masotti, Giancarlo Landini, Grazia Panigada

  48-58

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.48

  1607

  PDF: 1104
• 

  Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

  Luca Masotti, Mauro Campanini

  1-7

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.1

  13616

  PDF: 3218
• 

  Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

  Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

  134-140

  12-06-2014

  https://doi.org/10.4081/itjm.2014.450

  1835

  PDF: 1400

  Appendix: 637

  HTML: 632
• 

  Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

  Giancarlo Landini, Luca Masotti

  41-47

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.41

  1072

  PDF: 938
• 

  Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  8-21

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.8

  1531

  PDF: 1052
• 

  A review on management of antiphospholipid syndrome in clinical practice

  Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

  13-09-2023

  https://doi.org/10.4081/itjm.2023.1649

  3341

  PDF: 1348

  HTML: 82
• 

  Vorapaxar

  Gianluca Airoldi, Mauro Campanini

  88-95

  24-04-2013

  https://doi.org/10.4081/itjm.2013.88

  1353

  PDF: 779

  HTML: 235
• 

  Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

  Andrea Rubboli

  22-28

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.22

  1179

  PDF: 855

• Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

  Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

  25-11-2024

  https://doi.org/10.4081/itjm.2024.1846

  1396

  PDF: 543

  SUPPLEMENTARY MATERIAL: 310

  ACKNOWLEDGMENTS: 265

  HTML: 172
• 

  Apixaban

  Gianluca Airoldi, Mauro Campanini

  128-134

  07-03-2013

  https://doi.org/10.4081/itjm.2011.128

  1374

  PDF: 2070
• 

  New oral anticoagulants: key messages for clinicians

  Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

  74-84

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.74

  1445

  PDF: 1013
• 

  Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  153-169

  23-10-2012

  https://doi.org/10.4081/itjm.2012.153

  1862

  PDF: 2272
• 

  Cryptogenic stroke

  Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

  185-194

  30-09-2016

  https://doi.org/10.4081/itjm.2016.682

  2097

  PDF: 1289

  HTML: 610
• 

  Pregnancy and heart disease: what Internists should know

  Riccardo Gerloni, Domenico Panuccio

  288-304

  11-09-2017

  https://doi.org/10.4081/itjm.2017.815

  1673

  PDF: 832

  HTML: 280

• Acute severe renal failure in a patient receiving apixaban: a case report

  Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

  09-04-2024

  https://doi.org/10.4081/itjm.2024.1718

  1102

  PDF: 561

  HTML: 80
• 

  Sex differences in adverse drug reaction and liver disease

  Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

  15-22

  20-03-2018

  https://doi.org/10.4081/itjm.2018.893

  2392

  PDF: 1069

  HTML: 497
• 

  Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

  Aurelio Seidita, Delia Sprini, Accursia Bongiovì, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

  196-205

  19-09-2013

  https://doi.org/10.4081/itjm.2013.196

  2092

  PDF: 1344

  HTML: 2005
• 

  Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

  Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

  184-190

  14-06-2017

  https://doi.org/10.4081/itjm.2017.705

  1628

  PDF: 861

  HTML: 459

• ORAL COMMUNICATION | Comparison of HAS-BLED and DOAC score for bleeding risk prediction in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: a real-world cohort study.

  A. Trovati, S. Ballestri, M. Bergamini, F. Zanni, B. Cuneo, L. Orlandi, M. Pasquinelli, M. Capitelli

  22-05-2026

  https://doi.org/10.4081/itjm.2026.2579

  147

  PDF: 86
• 

  Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

  Federico Cacciapuoti

  136-142

  17-09-2020

  https://doi.org/10.4081/itjm.2020.1296

  1065

  PDF: 688

  HTML: 361

• Utility of the aspirin and P2Y12 response assays to determine the effects of antiplatelet agents in patients with subdural hematoma undergoing neurosurgery

  Ombretta Para, Christian Carleo, Francesco Bucci, Lucia Lipari, Asim Raza, Edoardo Cesaroni, Chiara La Rovere, Simone Orlandini, Gastone Pansini, Alberto Parenti, Giovanni Muscas, Alessandro Della Puppa

  14-07-2025

  https://doi.org/10.4081/itjm.2025.1926

  889

  PDF: 781

  HTML: 0
• 

  Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

  Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

  43-48

  17-06-2020

  https://doi.org/10.4081/itjm.2020.1224

  1204

  PDF: 744

  HTML: 252

• ORAL COMMUNICATION | Outcomes of direct oral anticoagulants in unusual-site thrombosis: impact of active cancer

  S. Guglielmo, M. Lovisotto, L. Scarano, E. De Bon, S. Barbar

  22-05-2026

  https://doi.org/10.4081/itjm.2026.2592

  149

  PDF: 89
• 

  Gender medicine: an up-date

  Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

  96-106

  24-04-2013

  https://doi.org/10.4081/itjm.2013.96

  2387

  PDF: 1040

  HTML: 502
• 

  A dangerous adverse event in the use of dabigatran

  Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

  250-251

  09-11-2015

  https://doi.org/10.4081/itjm.2015.629

  1764

  PDF: 1038

  HTML: 265
• 

  Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

  Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

  18-03-2021

  https://doi.org/10.4081/itjm.2021.1351

  1432

  PDF: 671

  HTML: 54
• 

  The management of the patient with acute pancreatitis: from evidence to clinical practice

  Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

  220-245

  11-09-2017

  https://doi.org/10.4081/itjm.2017.748

  3091

  PDF: 1348

  HTML: 1374

• Unveiling silent threats: incidental diagnosis and conservative management of spontaneous isolated celiac artery dissection

  Guido Faggian, Roberto Faggian, Michela Salzano, Ciro Stavolo, Teresa Argenziano, Andrea Diglio, Angela Faggian

  20-01-2026

  https://doi.org/10.4081/itjm.2026.2385

  331

  PDF: 209

  HTML: 15

• CO26 | Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer: a FADOI survey among Campanian Internal Medicine wards E. Marrone¹, C. Arturo², F. Cannavacciuolo³, D. D’Ambrosio⁴, F. Gallucci¹, M. Amitrano³, C. Di Gennaro², P. Morella¹, A. Maffettone⁵ | ¹UOC Medicina 3, AORN A Cardarelli, Napoli, ²UOC Medicina Generale, PO A. Rizzoli, Ischia (NA), ³UOC Medicina Interna, AO Moscati, Avellino, ⁴UOC Medicina Generale, PO Aversa (CE), ⁵UOC Medicina ad indirizzo cardiovascolare e dismetabolico AORN dei Colli, Ospedale Monaldi, Italy

  25-08-2025

  https://doi.org/10.4081/itjm.2025.2178

  228
• 

  Optimal duration of anticoagulant therapy in patients with venous thromboembolism

  Gualtiero Palareti

  235-244

  14-09-2018

  https://doi.org/10.4081/itjm.2018.1077

  1742

  PDF: 1942

  HTML: 260

• Quantifying treatment effect: relative and absolute measures in clinical research

  Alberto Maino, Lorenza Bertù, Alessandro Squizzato, Paola Piccolo, Fulvio Pomero

  16-04-2026

  https://doi.org/10.4081/itjm.2026.2386

  399

  PDF: 214

  HTML: 4
• 

  Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

  Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

  24-31

  03-01-2019

  https://doi.org/10.4081/itjm.2019.1111

  1529

  PDF: 895

  HTML: 71
• 

  Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge

  Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli

  218-230

  19-09-2013

  https://doi.org/10.4081/itjm.2013.218

  1763

  PDF: 1229

  HTML: 873
• 

  An unusual cause of massive hemoptysis

  Silvia Maestroni, Martino Cellerini, Antonio Brucato

  71-74

  01-07-2016

  https://doi.org/10.4081/itjm.2016.738

  1520

  PDF: 1043

  HTML: 390
• 

  The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

  Fernando Gallucci

  16-02-2023

  https://doi.org/10.4081/itjm.2023.1573

  2292

  PDF: 720

  HTML: 13
• 

  How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

  Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

  20-11-2023

  https://doi.org/10.4081/itjm.2023.1656

  1324

  PDF: 541

  HTML: 30

• P149 | Acute and long-term management of venous thromboembolism through the post-COVID-19 pandemic era M.A. Wu¹, A. Taino¹, P. Facchinetti¹, V. Rossi¹, S. Berra², R. Celano¹, F. Urso¹, A. Meschia¹, R. Colombo³ | ¹Division of Internal Medicine, Luigi Sacco Hospital, University of Milan, ²Department of Biomedical and Clinical Sciences, University of Milan, ³Division of Anesthesiology and Intensive Care, Luigi Sacco Hospital, University of Milan, Italy

  28-08-2025

  https://doi.org/10.4081/itjm.2025.2345

  172
• 

  Equivalent/generic drugs use. To whom? When? How?

  Andrea Fontanella

  77-79

  08-05-2014

  https://doi.org/10.4081/itjm.2014.472

  1196

  PDF: 939

  HTML: 284
• 

  The management of the patient with non-variceal upper gastrointestinal bleeding: from evidence to clinical practice

  Maddalena Zippi, Mariella Frualdo, Luciano Mucci, Marta Zanon, Chiara Marzano, Claudio Cassieri, Paola Gnerre, Pietro Crispino

  246-252

  27-12-2016

  https://doi.org/10.4081/itjm.2016.713

  1695

  PDF: 1114

  HTML: 300